Inactive Instrument

Spatializer Audio Laboratories, Inc. Share Price Other OTC

Equities

US84725L3096

End-of-day quote Other OTC
- USD - Intraday chart for Spatializer Audio Laboratories, Inc.
Sales 2024 * - Sales 2025 * 5M 415M Capitalization 5.69M 472M
Net income 2024 * -11M -913M Net income 2025 * -13M -1.08B EV / Sales 2024 * -
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.14 x
P/E ratio 2024 *
-0.44 x
P/E ratio 2025 *
-0.76 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 0%
More Fundamentals * Assessed data
Enveric Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Firefly Neuroscience Names David Johnson Executive Chairman, Following WaveDancer Merger MT
Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with Mindbio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders CI
Enveric Biosciences, Inc. Announces Signing of Non-Binding Term Sheet with Undisclosed License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids CI
Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sector Update: Health Care Stocks Rise Late Afternoon MT
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading MT
Enveric Biosciences Signs Licensing Term Sheets for Joint Disease Treatment Compounds; Shares Rise MT
Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected MT
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease CI
Enveric Biosciences Issues 228,690 Shares in Direct Offering MT
Top Midday Gainers MT
Wall Street Set to Open Higher Thursday as Inflation Data Meets Forecasts MT
Investors Await Slate of Economic Data as US Futures Move Lower in Thursday's Premarket Session MT
Sector Update: Health Care Stocks Rise in Late Afternoon MT
More news
Enveric Biosciences Inc., formerly AMERI Holdings, Inc., is a patient-central biotechnology company. The Company is focused on enhancing lives of people affected by the side effects of cancer treatments, such as radiodermatitis and chemotherapy-induced peripheral neuropathy. The Company is engaged in leveraging its clinical developments derived from cannabinoids and taps into its global network of scientists and oncology physicians. The Company is advancing its pipeline of new-generation of naturally occurring and synthetic compounds. It is developing product candidates that target skin-related ailments common among cancer patients, including radiodermatitis, pruritus, rashes and dry skin, as well as indications such as chemotherapy-induced peripheral neuropathy, with future areas of focus that may include depression, pain and anxiety.
Sector
-
More about the company